Based on our results and the established roles of ACSS2 in acetate usage7,27,28, ACSS2-driven high acetate uptake seems to be an inherent property of a normal liver that may be only slightly lost (if at all) in low-malignancy liver cancer but largely lost in high-malignancy liver cancer. Here, ACSS2 is linked to liver cancer.